Home
About Us
NIHR Imperial BRC Team
Equality, Diversity and Inclusion (EDI) Strategy
NIHR Infrastructures
Acknowledgement
NIHR Imperial BRC Branding Guidance
Research
Biomedical Engineering
Brain Sciences
Cardiovascular
Digestive Diseases
Digital Health
Immunology
Infection & Antimicrobial Resistance
Metabolic & Endocrinology
Molecular Phenotyping
Multiple Long-Term Conditions
Pregnancy & Prematurity
Respiratory
Social Genetic & Environmental Determinants of Health
Surgery & Cancer
Facilities/Services
Clinical Imaging Facility
Clinical Phenotyping Centre
Flow Cytometry
Genomics Facility
Imperial College Healthcare Tissue Bank
Imperial Clinical Analytics, Research and Evaluation (iCARE)
Imperial Clinical Trials Unit
Imperial Health Knowledge Bank (IHKB)
Organoid Facility
Patient Experience Research Centre (PERC)
The Leonard and Dora Colebrook Laboratory
Patient/Public
Research We Are Supporting
How You Can Get Involved
Information for Researchers
Public Involvement, Engagement and Participation in Research Summary Strategy
Industry/Partners
Collaborations
Contract
Commercialisation
Training
Non-Medical Opportunities
Chain-Florey Fellowships & Lecturers
Clinical Academic Training Office
Other Training Schemes
News & Events
Upcoming Events
Newsletter
Contact Us
Treatment Stories
Treatment
UK cancer patients receive experimental mRNA therapy for the first time
Published on
5
th
February 2024
Diagnostic
Prevention
Therapeutic
Treatment
Meet the Team Leading the Charge Against Cervical Cancer
Published on
29
th
January 2024
Diagnostic
Partnership
Therapeutic
Treatment
Antimicrobial Resistance: Securing the Future
Published on
5
th
December 2023
Treatment
New world-first gene-editing treatment for blood disorders gets the green light
Published on
16
th
November 2023
« Previous page